Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape
Qianqian Li, Jianhui Nie, Jiajing Wu, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2362-2371.e9
Open Access | Times Cited: 382

Showing 1-25 of 382 citing articles:

SARS-CoV-2 variants, spike mutations and immune escape
William T. Harvey, Alessandro M. Carabelli, Ben Jackson, et al.
Nature Reviews Microbiology (2021) Vol. 19, Iss. 7, pp. 409-424
Open Access | Times Cited: 3420
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Yunlong Cao, Jing Wang, Fanchong Jian, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 657-663
Open Access | Times Cited: 1784
The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 993
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
Markus Hoffmann, Nadine Krüger, Sebastian Schulz, et al.
Cell (2021) Vol. 185, Iss. 3, pp. 447-456.e11
Open Access | Times Cited: 878
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Chihiro Motozono, Mako Toyoda, Jiří Zahradník, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1124-1136.e11
Open Access | Times Cited: 525
SARS-CoV-2 Omicron variant: recent progress and future perspectives
Yao Fan, Xiang Li, Lei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 484
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
Pengcheng Han, Linjie Li, Sheng Liu, et al.
Cell (2022) Vol. 185, Iss. 4, pp. 630-640.e10
Open Access | Times Cited: 459
The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant
Dandan Tian, Yanhong Sun, Huihong Xu, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2376-2383
Open Access | Times Cited: 441
The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron
Li Zhang, Qianqian Li, Ziteng Liang, et al.
Emerging Microbes & Infections (2021) Vol. 11, Iss. 1, pp. 1-5
Open Access | Times Cited: 374
COVID-19 vaccine development: milestones, lessons and prospects
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 342
Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
Changshuo Wei, Ke-Jia Shan, Wei‐Guang Wang, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2021) Vol. 48, Iss. 12, pp. 1111-1121
Open Access | Times Cited: 271
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
Baoqi Zeng, Le Gao, Qingxin Zhou, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 241
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, et al.
Cell Reports (2021) Vol. 36, Iss. 3, pp. 109415-109415
Open Access | Times Cited: 233
Impact of the Delta variant on vaccine efficacy and response strategies
Lianlian Bian, Qiushuang Gao, Fan Gao, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 10, pp. 1201-1209
Open Access | Times Cited: 218
SARS-COV-2 Variants: Differences and Potential of Immune Evasion
Sandro Massao Hirabara, Tamires Duarte Afonso Serdan, Renata Gorjão, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 208
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183
Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay
Anoop Narayanan, M. Narwal, Sydney A. Majowicz, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 181
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
Gary R. McLean, Jeremy P. Kamil, Benhur Lee, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 179
SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63
Bezawit A. Woldemeskel, Caroline C. Garliss, Joel N. Blankson
Journal of Clinical Investigation (2021) Vol. 131, Iss. 10
Open Access | Times Cited: 172
Emerging SARS-CoV-2 variants expand species tropism to murines
Huiping Shuai, Jasper Fuk‐Woo Chan, Terrence Tsz‐Tai Yuen, et al.
EBioMedicine (2021) Vol. 73, pp. 103643-103643
Open Access | Times Cited: 171
Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
Yunlong Cao, Ayijiang Yisimayi, Yali Bai, et al.
Cell Research (2021) Vol. 31, Iss. 7, pp. 732-741
Open Access | Times Cited: 156
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19
Lok-Yin Roy Wong, Jian Zheng, Kevin Wilhelmsen, et al.
Nature (2022) Vol. 605, Iss. 7908, pp. 146-151
Open Access | Times Cited: 140
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment
Dapeng Li, Gregory D. Sempowski, Kevin O. Saunders, et al.
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 1-16
Closed Access | Times Cited: 133
The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivity
Yongbing Zhou, Hui‐Lin Zhi, Yong Teng
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 133
Antibody and B cell responses to SARS-CoV-2 infection and vaccination
Katharina Röltgen, Scott D. Boyd
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1063-1075
Open Access | Times Cited: 129
Page 1 - Next Page

Scroll to top